VCYT - Company ID 0001384101
The table below shows VERACYTE, INC.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $139.07M | $131.87M | $130.16M | $114.47M | $115.86M | $114.43M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | $101.16M | $91.28M | $89.77M | $79.51M | $79.01M | $77.91M |
| R&D | $27.10M | $15.98M | $16.26M | $17.72M | $17.57M | $16.46M |
VERACYTE, INC. reported annual revenue of $517.14M for fiscal year 2025. That is up 16.0% from $445.76M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $65.08M (FY 2016) to $517.14M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $23.68M |
| $27.28M |
| $32.33M |
| $33.81M |
| $25.74M |
| $31.75M |
| Operating income | $22.65M | $22.95M | -$5.27M | $2.90M | $12.02M | $4.61M |
| Income tax | $1.27M | -$248.00K | $2.23M | $381.00K | $1.69M | $1.63M |
| Net income | $28.71M | $19.14M | -$980.00K | $7.05M | $15.15M | $5.73M |
| EPS (diluted) | $0.35 | $0.24 | -$0.01 | $0.09 | $0.19 | $0.07 |